NovartisNOVN 
$97.381.11%24h
1.11%24h
Global rank62
Market cap$200.16B
Change 7d0.05%
YTD Performance-
SP500 benchmark
P/E0
P/S4.29
Revenue$46.66B
Earnings$14.85B
Dividend yield3.6%
Main Sector
Healthcare
Market capitalization of Novartis (NOVN)
As of January 2025, Novartis has a market cap of $200.16B. This makes Novartis the world's 62th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Novartis from 1995 to 2024
-
Value:-
Market cap history of Novartis from 1995 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $200.80B | 3.64% |
| 2023 | $193.74B | 1.53% |
| 2022 | $190.82B | 4.12% |
| 2021 | $183.27B | -4.03% |
| 2020 | $190.96B | -8.98% |
| 2019 | $209.79B | 23.70% |
| 2018 | $169.59B | 1.99% |
| 2017 | $166.28B | 11.20% |
| 2016 | $149.53B | -14.63% |
| 2015 | $175.16B | -6.01% |
| 2014 | $186.36B | 29.71% |
| 2013 | $143.68B | 23.93% |
| 2012 | $115.93B | 6.98% |
| 2011 | $108.37B | -2.27% |
| 2010 | $110.89B | -3.43% |
| 2009 | $114.82B | 7.97% |
| 2008 | $106.35B | -15.14% |
| 2007 | $125.32B | -11.60% |
| 2006 | $141.76B | 1.74% |
| 2005 | $139.34B | 20.51% |
| 2004 | $115.63B | 2.05% |
| 2003 | $113.31B | 11.30% |
| 2002 | $101.81B | -15.92% |
| 2001 | $121.08B | -16.23% |
| 2000 | $144.54B | 8.32% |
| 1999 | $133.43B | -13.41% |
| 1998 | $154.09B | 13.92% |
| 1997 | $135.26B | 61.80% |
| 1996 | $83.60B | 52.54% |
| 1995 | $54.80B | - |
NOVN Market Cap Today is $200.16B 1.11% - 19 Jan 2025
View largest stocks by market cap 
